1   PREFACE
2   SCOPE AND METHODOLOGY
    2.1    OBJECTIVES OF THE STUDY
    2.2    STAKEHOLDERS
    2.3    DATA SOURCES
        2.3.1    PRIMARY SOURCES
        2.3.2    SECONDARY SOURCES
    2.4    MARKET ESTIMATION
        2.4.1    BOTTOM-UP APPROACH
        2.4.2    TOP-DOWN APPROACH
    2.5    FORECASTING METHODOLOGY

3   EXECUTIVE SUMMARY
4   JAPAN HOME INFUSION THERAPY MARKET - INTRODUCTION
    4.1    OVERVIEW
    4.2    MARKET DYNAMICS
    4.3    INDUSTRY TRENDS
    4.4    COMPETITIVE INTELLIGENCE

5   JAPAN HOME INFUSION THERAPY MARKET LANDSCAPE
    5.1    HISTORICAL AND CURRENT MARKET TRENDS 
    5.2    MARKET FORECAST (2025-2033)

6   JAPAN HOME INFUSION THERAPY MARKET - BY PRODUCT
    6.1    INFUSION PUMPS AND SETS
        6.1.1 OVERVIEW
        6.1.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.1.3 MARKET FORECAST (2025-2033)
    6.2    CATHETERS AND CANNULAS
        6.2.1 OVERVIEW
        6.2.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.2.3 MARKET FORECAST (2025-2033)
    6.3    NEEDLES AND SYRINGES
        6.3.1 OVERVIEW
        6.3.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.3.3 MARKET FORECAST (2025-2033)
    6.4    CONSUMABLES AND ACCESSORIES
        6.4.1 OVERVIEW
        6.4.2 HISTORICAL AND CURRENT MARKET TRENDS 
        6.4.3 MARKET FORECAST (2025-2033)

7   JAPAN HOME INFUSION THERAPY MARKET - BY APPLICATIONS
    7.1    TOTAL PARENTERAL NUTRITION (TPN)
        7.1.1 OVERVIEW
        7.1.2 HISTORICAL AND CURRENT MARKET TRENDS 
        7.1.3 MARKET FORECAST (2025-2033)
    7.2    ANTI-INFECTIVE THERAPY
        7.2.1 OVERVIEW
        7.2.2 HISTORICAL AND CURRENT MARKET TRENDS 
        7.2.3 MARKET FORECAST (2025-2033)
    7.3    ENTERAL NUTRITION
        7.3.1 OVERVIEW
        7.3.2 HISTORICAL AND CURRENT MARKET TRENDS 
        7.3.3 MARKET FORECAST (2025-2033)
    7.4    HYDRATION THERAPY
        7.4.1 OVERVIEW
        7.4.2 HISTORICAL AND CURRENT MARKET TRENDS 
        7.4.3 MARKET FORECAST (2025-2033)
    7.5    CHEMOTHERAPY
        7.5.1 OVERVIEW
        7.5.2 HISTORICAL AND CURRENT MARKET TRENDS 
        7.5.3 MARKET FORECAST (2025-2033)
    7.6    IV IMMUNOGLOBULIN (IVIG) THERAPY
        7.6.1 OVERVIEW
        7.6.2 HISTORICAL AND CURRENT MARKET TRENDS 
        7.6.3 MARKET FORECAST (2025-2033)
    7.7    PAIN MANAGEMENT
        7.7.1 OVERVIEW
        7.7.2 HISTORICAL AND CURRENT MARKET TRENDS 
        7.7.3 MARKET FORECAST (2025-2033)
    7.8    SPECIALTY PHARMACEUTICALS
        7.8.1 OVERVIEW
        7.8.2 HISTORICAL AND CURRENT MARKET TRENDS 
        7.8.3 MARKET FORECAST (2025-2033)

   8   JAPAN HOME INFUSION THERAPY MARKET – BY DELIVERY MODEL
    8.1    HOSPITAL-BASED HOME INFUSION
        8.1.1 OVERVIEW
        8.1.2 HISTORICAL AND CURRENT MARKET TRENDS 
        8.1.6 MARKET FORECAST (2025-2033)
    8.2    INDEPENDENT HOME INFUSION PROVIDERS
        8.2.1 OVERVIEW
        8.2.2 HISTORICAL AND CURRENT MARKET TRENDS 
        8.2.6 MARKET FORECAST (2025-2033)
    8.3    SPECIALTY PHARMACIES
        8.3.1 OVERVIEW
        8.3.2 HISTORICAL AND CURRENT MARKET TRENDS 
        8.3.6 MARKET FORECAST (2025-2033)

   9   JAPAN HOME INFUSION THERAPY MARKET – COMPETITIVE LANDSCAPE
    9.1    OVERVIEW
    9.2    MARKET STRUCTURE
    9.3    MARKET PLAYER POSITIONING
    9.4    TOP WINNING STRATEGIES
    9.5    COMPETITIVE DASHBOARD
    9.6    COMPANY EVALUATION QUADRANT

10  PROFILES OF KEY PLAYERS
    10.1    TERUMO CORPORATION
        10.1.1 BUSINESS OVERVIEW
        10.1.2 SERVICES OFFERED
        10.1.3 BUSINESS STRATEGIES
        10.1.4 SWOT ANALYSIS
        10.1.5 MAJOR NEWS AND EVENTS
    10.2    NIPRO CORPORATION
        10.2.1 BUSINESS OVERVIEW
        10.2.2 SERVICES OFFERED
        10.2.3 BUSINESS STRATEGIES
        10.2.4 SWOT ANALYSIS
        10.2.5 MAJOR NEWS AND EVENTS
    10.3    BAXTER INTERNATIONAL
        10.3.1 BUSINESS OVERVIEW
        10.3.2 SERVICES OFFERED
        10.3.3 BUSINESS STRATEGIES
        10.3.4 SWOT ANALYSIS
        10.3.5 MAJOR NEWS AND EVENTS
    10.4    ICU MEDICAL (SMITHS MEDICAL)
        10.4.1 BUSINESS OVERVIEW
        10.4.2 SERVICES OFFERED
        10.4.3 BUSINESS STRATEGIES
        10.4.4 SWOT ANALYSIS
        10.4.5 MAJOR NEWS AND EVENTS
    10.5    BECTON, DICKINSON AND COMPANY (BD)
        10.5.1 BUSINESS OVERVIEW
        10.5.2 SERVICES OFFERED
        10.5.3 BUSINESS STRATEGIES
        10.5.4 SWOT ANALYSIS
        10.5.5 MAJOR NEWS AND EVENTS
    10.6    FRESENIUS KABI
        10.6.1 BUSINESS OVERVIEW
        10.6.2 SERVICES OFFERED
        10.6.3 BUSINESS STRATEGIES
        10.6.4 SWOT ANALYSIS
        10.6.5 MAJOR NEWS AND EVENTS
    10.7    OPTION CARE HEALTH
        10.7.1 BUSINESS OVERVIEW
        10.7.2 SERVICES OFFERED
        10.7.3 BUSINESS STRATEGIES
        10.7.4 SWOT ANALYSIS
        10.7.5 MAJOR NEWS AND EVENTS
    10.8    MEDTRONIC
        10.8.1 BUSINESS OVERVIEW
        10.8.2 SERVICES OFFERED
        10.8.3 BUSINESS STRATEGIES
        10.8.4 SWOT ANALYSIS
        10.8.5 MAJOR NEWS AND EVENTS
    10.9    B. BRAUN MELSUNGEN AG
        10.9.1 BUSINESS OVERVIEW
        10.9.2 SERVICES OFFERED
        10.9.3 BUSINESS STRATEGIES
        10.9.4 SWOT ANALYSIS
        10.9.5 MAJOR NEWS AND EVENTS
    10.10    CAREFUSION CORPORATION
        10.10.1 BUSINESS OVERVIEW
        10.10.2 SERVICES OFFERED
        10.10.3 BUSINESS STRATEGIES
        10.10.4 SWOT ANALYSIS
        10.10.5 MAJOR NEWS AND EVENTS

11  JAPAN HOME INFUSION THERAPY MARKET - INDUSTRY ANALYSIS
    11.1    DRIVERS, RESTRAINTS, AND OPPORTUNITIES
        11.1.1 OVERVIEW
        11.1.2 DRIVERS
        11.1.3 RESTRAINTS
        11.1.4 OPPORTUNITIES
    11.2   PORTERS FIVE FORCES ANALYSIS
        11.2.1 OVERVIEW
        11.2.2 BARGAINING POWER OF BUYERS
        11.2.3 BARGAINING POWER OF SUPPLIERS
        11.2.4 DEGREE OF COMPETITION
        11.2.5 THREAT OF NEW ENTRANTS
        11.2.6 THREAT OF SUBSTITUTES
    11.3    VALUE CHAIN ANALYSIS
12  APPENDIX